Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters

被引:19
作者
Ege, T [1 ]
Canbaz, S [1 ]
Yuksel, V [1 ]
Duran, E [1 ]
机构
[1] Trakya Univ, Fac Med, Dept Cardiovasc Surg, TR-22030 Edirne, Turkey
关键词
coronary artery bypass surgery; interleukin; pericardial cytokines; pericardial fluid; tumor necrosis factor;
D O I
10.1016/S1043-4666(03)00180-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effects of pro-inflammatory cytokines of pericardial fluid on hemodynamic parameters in patients undergoing coronary artery surgery. Seventy-eight patients were included in the study and they were allocated to three groups: group I, stable angina pectoris (SAP, n = 15); group 2, unstable angina pectoris (USAP, n = 34); group 3, post-myocardial infarction (PMI, n = 29). Pericardial fluid and arterial blood samples were obtained from all patients and interleukin (IL)-1beta, IL-2 receptor, IL-6, IL-8 and tumor necrosis factor-alpha (TNF-alpha) levels were measured. Pericardial IL-1beta concentration (pg/mL) was significantly higher in the USAP group (26.6 +/- 10.9) compared to the SAP (5.0 +/- 0.1) and PMI (5.8 +/- 1.0) groups. IL-2R, IL-6, IL-8 and TNF-a concentrations of pericardial fluid were significantly higher than serum in all groups; difference was more prominent in the PMI group compared to the SAP and the USAP groups. Serum IL-1beta concentrations (pg/mL) were significantly higher in the USAP group (21.8 +/- 3.4) compared to the SAP group (5.0 +/- 0.1) and the PMI group (5.4 +/- 11.6). Cardiac index (CI) before opening the pericardial sac was found to be lower in the USAP group (1.6 +/- 0.3 L/min/m(2)) compared to the SAP (2.2 +/- 0.5 L/min/m(2)) and the PMI (2.1 +/- 0.5 L/min/m(2)) groups (p = 0.028 and p = 0.011, respectively). In the USAP group, there was a relationship between reduction of CI and increase of IL-1beta levels in serum and pericardial fluid. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 24 条
[1]   Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events [J].
Biasucci, LM ;
Liuzzo, G ;
Fantuzzi, G ;
Caligiuri, G ;
Rebuzzi, AG ;
Ginnetti, F ;
Dinarello, CA ;
Maseri, A .
CIRCULATION, 1999, 99 (16) :2079-2084
[2]   Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury [J].
Boyle, EM ;
Kovacich, JC ;
Hèbert, CA ;
Canty, TG ;
Chi, E ;
Morgan, EN ;
Pohlman, TH ;
Verrier, ED .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (01) :114-120
[3]  
Corda S, 1997, CIRC RES, V81, P679
[4]  
DAVIS LS, 1993, TXB RHEUMATOLOGY, P95
[5]   INTERLEUKIN-6 (IL-6) AS A MEDIATOR OF STUNNED MYOCARDIUM [J].
FINKEL, MS ;
HOFFMAN, RA ;
SHEN, L ;
ODDIS, CV ;
SIMMONS, RL ;
HATTLER, BG .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (13) :1231-1232
[6]   Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion [J].
Frangogiannis, NG ;
Lindsey, ML ;
Michael, LH ;
Youker, KA ;
Bressler, RB ;
Mendoza, LH ;
Spengler, RN ;
Smith, CW ;
Entman, ML .
CIRCULATION, 1998, 98 (07) :699-710
[7]   INTERLEUKIN-1-MEDIATED RELEASE OF INTERLEUKIN-8 BY ASBESTOS-STIMULATED HUMAN PLEURAL MESOTHELIAL CELLS [J].
GRIFFITH, DE ;
MILLER, EJ ;
GRAY, LD ;
IDELL, S ;
JOHNSON, AR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (03) :245-252
[8]   Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions [J].
Gwechenberger, M ;
Mendoza, LH ;
Youker, KA ;
Frangogiannis, NG ;
Smith, CW ;
Michael, LH ;
Entman, ML .
CIRCULATION, 1999, 99 (04) :546-551
[9]   Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction [J].
Kotajima, N ;
Kimura, T ;
Kanda, T ;
Kuwabara, A ;
Fukumura, Y ;
Murakami, M ;
Kobayashi, I .
HEART, 2001, 86 (06) :704-704
[10]   Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease - Effects of an early invasive or noninvasive strategy [J].
Lindmark, E ;
Diderholm, E ;
Wallentin, L ;
Siegbahn, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (17) :2107-2113